Candel Therapeutics (CADL) Times Interest Earned (2020 - 2025)
Candel Therapeutics (CADL) posted Times Interest Earned of -$27.3 for Q4 2025, down 2255.43% sequentially from -$1.16 in Q3 2025, and down 110.59% YoY from $257.74 in Q4 2024.
Candel Therapeutics (CADL) Times Interest Earned (2020 - 2025) Analysis & Trends
Candel Therapeutics has reported Times Interest Earned for 6 years, with the latest figure at -$27.3 in Q4 2025.
- Quarterly Times Interest Earned fell 110.59% year-over-year to -$27.3 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$23.24 (down 51.04% YoY) and the FY2025 annual result came in at -$0.74, up 38.84% from the prior year.
- Times Interest Earned fell to -$27.3 in Q4 2025 per CADL's latest filing, from -$1.16 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.31 in Q1 2022 and troughed at -$45.65 in Q4 2023.
- A 5-year average of -$10.94 and a median of -$12.23 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned plunged 5033.99% in 2023, then jumped 96.74% in 2024.
- Over 5 years, Times Interest Earned stood at -$0.42 in 2021, then slumped by 3771.11% to -$16.2 in 2022, then plunged by 181.79% to -$45.65 in 2023, then soared by 71.61% to -$12.96 in 2024, then plunged by 110.59% to -$27.3 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$27.3, -$1.16, and -$0.99 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Candel Therapeutics | 643.41 Mn | 643.41 Mn | - | -27.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.30 |
| Sep 30, 2025 | -1.16 |
| Jun 30, 2025 | -0.99 |
| Mar 31, 2025 | -0.59 |
| Dec 31, 2024 | -12.96 |
| Sep 30, 2024 | -0.43 |
| Jun 30, 2024 | -0.49 |
| Mar 31, 2024 | -12.23 |
| Dec 31, 2023 | -45.65 |
| Sep 30, 2023 | -13.25 |
| Jun 30, 2023 | -0.96 |
| Mar 31, 2023 | -15.82 |
| Dec 31, 2022 | -16.20 |
| Sep 30, 2022 | -17.11 |
| Jun 30, 2022 | -20.12 |
| Mar 31, 2022 | -0.31 |
| Dec 31, 2021 | -0.42 |
| Dec 31, 2020 | -0.54 |